Li, Chuan-Yuan, Shan, Siqing, Huang, Qian, Braun, Rod D., Lanzen, Jennifer, Hu, Kang, ...
BACKGROUND: There is a paucity of information about events that follow immediately after tumor cells are triggered to initiate the process of angiogenesis (the formation of new blood vessels). Such...
Hughes, G.Chad, Annex, Brian H., Yin, Bangliang, Pippen, Anne M., Lin, Pengnian, Kypson, Alan P., ...
Objective: Transmyocardial laser revascularization (TMR) is emerging as a potential treatment option for patients with end-stage CAD, and adjuvant gene therapy may be helpful in further improving the...
Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
Lin, Pengnian, Buxton, Jake A., Acheson, Ann, Radziejewski, Czeslaw, Maisonpierre, Peter C., Yancopoulos, George D., ...
Angiogenesis is required for tumor growth and metastasis, and inhibition of angiogenesis is a promising approach for anticancer therapy. Tie2 (a.k.a Tek) is an endothelium-specific receptor tyrosine...
Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
Lin, Pengnian, Buxton, Jake A., Acheson, Ann, Radziejewski, Czeslaw, Maisonpierre, Peter C., Yancopoulos, George D., ...
Angiogenesis is required for tumor growth and metastasis, and inhibition of angiogenesis is a promising approach for anticancer therapy. Tie2 (a.k.a Tek) is an endothelium-specific receptor tyrosine...